GlobeNewswire
-
NeOnc CEO Buys More Shares Below $5 as NTHI Secures FDA Meeting to Discuss Phase 3 Trial
12/11/2026 -
NYC Mommy Makeover Center Supports Local Moms as Mommy Makeover Interest Jumps 60%
12/11/2026 -
ALK to present positive phase II data on its tablet for the treatment of peanut allergy at ACAAI 2026
12/11/2026 -
Intellia Therapeutics Presents Additional Positive Clinical and Patient-Reported Data for Lonvoguran Ziclumeran (lonvo-z) at ACAAI 2026
12/11/2026 -
CCP Now Lansdale Brings Specialized Walk-In Cardiac Care to Montgomery County
12/11/2026 -
New Study Links Fitness Engagement to Lower Medicare Inpatient Costs
12/11/2026 -
Jersey College to Graduate First Nursing Class From Its Dothan, Alabama, Campus
12/11/2026 -
Resilio Mental Health Solutions Celebrates New Exton Office with Chamber Ribbon Cutting
12/11/2026 -
Aravax Announces Positive Results of Phase 2 Clinical Trial of PVX108, a Novel Immunotherapy for the Treatment of Peanut Allergy
12/11/2026 -
DBV Technologies Highlights New Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years
12/11/2026 -
DBV Technologies présente de nouvelles données issues de l’étude de phase 3 VITESSE sur le patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans
12/11/2026 -
HerScan CEO CiCi McMullen Featured in Forbes for Leadership in Expanding Breast Health Screenings
12/11/2026 -
NeOnc Insider Buying Expands Ahead of FDA Discussions and Two Key Brain Cancer Data Presentations
12/11/2026 -
Olema Oncology Announces Corporate Name Change
12/11/2026 -
LiveWorld Reports Third Quarter 2026 Financial Results
12/11/2026 -
Olympia Pharmaceuticals to Compound Select Peptides Under HHS Interim Enforcement Policy
12/11/2026 -
Medicana Expert Highlights: New Study Finds Better One-Year Outcomes After Robot-Assisted Knee Replacement
12/11/2026 -
Alps Group Inc Launches Pharmaco-Interaction (PCI) Unit via MyGenome, Debuting with CYP450 Drug Interaction Testing
12/11/2026 -
HOLLYWOOD HAS THE FANS. WHO BUILDS THE BUSINESS?
12/11/2026
Pages